Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.
Rewind Therapeutics's investors include Boehringer Ingelheim Venture Fund, M Ventures, PMV, Sunstone Life Science Ventures, Agentschap Innoveren & Ondernemen.
Rewind Therapeutics is headquartered in Heverlee, Belgium.
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.
Rewind Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rewind Therapeutics — Funding & Investors." VCBacked, October 6, 2026, https://www.vcbacked.co/company/rewind-therapeutics. Accessed November 13, 2026.
VCBacked. (2026). Rewind Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/rewind-therapeutics
{{cite web |title=Rewind Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rewind-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Rewind Therapeutics? Request a listing update